InsidersTradesSigma
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Browse the full record of transactions filed by Ezekowitz Alan. Director active across 2 companies, notably Septerna, Inc.. In total, 3 disclosures have been logged. Split: 2 buys · 1 sell. Total volume traded: €131k. History available since 4 March 2025. The latest transaction was disclosed on 7 March 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Ezekowitz Alan is a declarant and is listed as a director at Septerna, Inc. and Fulcrum Therapeutics, Inc. Across 3 filings, the 3 sampled filings cover the period from 2025-03-06 to 2026-06-30, with EUR 130875 of buys and EUR 0 of sells, and the modal transaction nature is Acquisition.